Determination of the inactivation kinetics of hepatitis A virus in human plasma products using a simple TCID50 assay

Journal of Medical Virology

Volumn 49, Issue 1, 1996, Pages 1-6

  Barrett, P N ^a   Meyer, H ^a   Wachtel, I ^a   Eibl, J ^a   Dorner, F ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Cytopathic strain; HAV titration; Vapor heating

Indexed keywords

HEPATITIS A VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

BLOOD CLOTTING FACTOR 8;

ARTICLE; BLOOD; CONTROLLED STUDY; DRUG CONTAMINATION; FREEZE DRYING; HEALING; HEPATITIS A VIRUS; HUMAN; NONHUMAN; TITRIMETRY; VIRUS INACTIVATION;

ANIMALS; ANTITHROMBIN III; BLOOD SUBSTITUTES; CELL LINE; CERCOPITHECUS AETHIOPS; CYTOPATHOGENIC EFFECT, VIRAL; ENCEPHALITIS VIRUSES, TICK-BORNE; HEAT; HEPATOVIRUS; HERPESVIRUS 1, SUID; HIV-1; HUMANS; KINETICS; MINUTE VIRUS OF MICE; PLAQUE ASSAY; TITRIMETRY; TUMOR CELLS, CULTURED;

EID: 0029885185     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199605)49:1<1::AID-JMV1>3.0.CO;2-A     Document Type: Article

References (24)

1. Cohen JI, Ticehurst JR, Purcell RH, Buckler-White A, Baroudy BM (1987a): Complete nucleotide sequence of wild-type hepatitis A virus: Comparison with different strains of hepatitis A virus and other picornaviruses. Journal of Virology 61:50-59.
2. Cohen JI, Ticehurst JR, Feinstone SM, Rosenblum B, Purcell RH (1987b): Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture. Journal of Virology 61:3035-3039.
3. Cramer EM (1964): Some comparisons of methods of fitting the dosage response curve for small samples. Journal of American Statistical Association 59:779-793.
4. Cromeans T, Fields HA, Sobsey MD (1989): Replication kinetics and cytopathic effect of hepatitis A virus. Journal of General Virology 70:2051-2062.
5. Daemer RJ, Feinstone SM, Gust ID, Purcell RH (1981): Propagation of human hepatitis A virus in African green monkey cell culture: Primary isolation and serial passage. Infection and Immunity 32.388-393.
6. Dorner F, Barrett PN, Eibl J (1993): At what stage should virus inactivation be carried out in human blood products. In Virological Safety Aspects of Plasma Derivatives. Developments in Biological Standardization. Basel: Karger, 81:137-143.
7. Gellis SS, Neefe JR, Stokes J Jr., Strong LE, Janeway CA, Scatchard G (1948): Chemical, clinical, and immunological studies on the products of human plasma fractionation. XXXVI. Inactivation of the virus of homologous serum hepatitis in solutions of normal human serum albumin by means of heat Journal of Clinical Investigation 27:239-244.
8. Gerritzen A, Schneweis KE, Brackmann H-H, Oldenburg J, Hanfland P, Gerlich WH, Caspari G (1992): Acute hepatitis A in haemophiliacs. The Lancet 340:1231-1232.
9. Hart HF, Hart WG, Crossley J, Perrie A-M, Wood DJ, John A, McOmish F (1994): Effect of terminal (dry) heat treatment on non-enveloped viruses in coagulation factor concentrates. Vox Sanguinis 67 340-350.
10. Holleman WH, Coen LJ, Capobianco JO, Barlow GH (1977): Isolation of human antithrombin III by affinity chromatography on heparinagarose. Thrombosis and Haemostasis 38:201.
11. Hollinger FB, Khan NC, Oefinger PE, Yawn DH, Schmulen AC, Dreesman GR, Melnick JL (1983): Posttransfusion hepatitis type A. JAMA 250:2313-2317.
12. Karron RA, Daemer R, Ticehurst J, Hondt ED, Popper H, Mihalik K, Phillips J, Feinstone S, Purcell RH (1988): Studies of prototype live hepatitis A virus vaccines in primate model. Journal of Infectious Diseases 157:338-345.
13. Krugman S, Ward R, Giles JP (1962): The natural history of infectious hepatitis. American Journal of Medicine 32:717-728.
14. Kurth R, Werner A, Barrett PN, Dorner F (1986): Stability and inactivation of the human immunodeficiency virus (HTV). AIDS Forschung 11:601-608.
15. Lemon SM (1994): The natural history of hepatitis A: The potential for transmission by transfusion of blood or blood products. Vox Sanguinis 67(suppl 4):19-23.
16. Lemon SM, Binn LN, Marchwicki RH (1983): Radioimmunofocus assay for quantitation of hepatitis A virus in cell cultures. Journal of Clinical Microbiology 17:834-839.
17. Lemon SM, Murphy PC, Shields PA, Ping L, Feinstone SM, Cromeans T. Jansen R (1991): Antigenic and genetic variation in cytopathic hepatitis A virus variants arising during persistent infection: Evidence for genetic recombination. Journal of Virology 65:2056-2065.
18. Lemon SM, Murphy PC, Smith A, Zou J, Aammon J, Robinson S, Horowitz B (1994): Removal/neutralization of hepatitis A virus during manufacture of high purity, solvent/detergent factor VIII concentrate. Journal of Medical Virology 43:44-49.
19. Mannucci PM (1992): Outbreak of hepatitis A among Italian patients with haemophilia. The Lancet 339:819.
20. Peerlinck K, Vermylen J (1993): Acute hepatitis A in patients with haemophilia A. The Lancet 341:179.
21. Provost PJ, Hilleman MR (1979): Propagation of human hepatitis A virus in cell culture in vitro. Proceedings of the Society for Experimental Biology and Medicine 160:213-221.
22. Sheretz RJ, Russel BA, Reuman PD (1984). Transmission of hepatitis A by transfusion of blood products. Archives of Internal Medicine 144:1579.
23. Tedeschi V, Purcell RH, Emerson SU (1993): Partial characterization of hepatitis A viruses from three intermediate passage levels of a series resulting in adaption to growth in cell culture and attenuation of virulence. Journal of Medical Virology 39:16-22.
24. Temperley IJ, Cotter KP, Walsh TJ, Power J, Hillary IB (1992): Clotting factors and hepatitis A. The Lancet 340:1466.